Market Cap 127.19M
Revenue (ttm) 60,000.00
Net Income (ttm) -55.48M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -92,466.67%
Debt to Equity Ratio 0.00
Volume 259,400
Avg Vol 432,358
Day's Range N/A - N/A
Shares Out 62.96M
Stochastic %K 5%
Beta -0.23
Analysts Strong Sell
Price Target $7.12

Company Profile

Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.

Industry: Biotechnology
Sector: Healthcare
Phone: 877 245 2787
Address:
3580 Carmel Mountain Road, Suite 200, San Diego, United States
stevie2times
stevie2times Aug. 3 at 7:03 AM
$CNTB 2 bucks, For Rademikibart that has created a completely new therapeutic Class Hyper -acute Respiratory Biologic. When you bypass the maintenance timeline of Dupixent dominance & capture the immediate point-of care network from the ER w a 300mg IV Push,& stuff a prescription of Rademikibart 600mg for monthly maintenance the addressable financial premium skyrockets. Rademikibart will literally be a Closed Loop Respiratory Franchise that also has Best in Class Eczema data, all this for 2 fkn bucks. Ciao' 😏
2 · Reply
stevie2times
stevie2times Aug. 2 at 4:47 AM
$CNTB 😂 This stock can't catch a bid' Even though July 30th the FDA's DPACC (Division of Pulmonology, Allergy, & Critical Care) green lighted the new protocol arm of the SEABREEZE trial after a 30 day review. The new delivery 300mg IV Push in the same ER setting were no biologic has even attempted is Rademikibart playground. Btw' that DPACC green light last Thurs just completely de'risked the SEABREEZE trial. Ciao' 😏
1 · Reply
SHVR89
SHVR89 Aug. 1 at 10:23 PM
0 · Reply
mikeywo
mikeywo Jul. 31 at 7:39 PM
$CNTB hopefully if we get some good data in Sept , Barry will go on a road show to all the healthcare conferences that occur in the fall and get the word out.
0 · Reply
BennyBoy18
BennyBoy18 Jul. 31 at 4:16 PM
$CNTB As long as James Huang is holding , im holding.
1 · Reply
BennyBoy18
BennyBoy18 Jul. 30 at 12:03 PM
$CNTB always blasts off pre marker and then crashes at marker open lol
1 · Reply
stevie2times
stevie2times Jul. 30 at 7:48 AM
$CNTB Tutes' have been busy scooping the STOPS
1 · Reply
Teshuvah
Teshuvah Jul. 29 at 12:16 PM
0 · Reply
elmono
elmono Jul. 28 at 9:18 PM
$CNTB dipping some more…..charts…what can I say 😂😂😂
1 · Reply
elmono
elmono Jul. 28 at 9:14 PM
$CNTB too funny 😂😂😂
0 · Reply
Latest News on CNTB
Connect Biopharma Holdings Slides: Corporate presentation

Jul 14, 2026, 9:00 AM EDT - 20 days ago

Connect Biopharma Holdings Slides: Corporate presentation


Connect Biopharma initiated with an Outperform at Oppenheimer

2026-07-09T12:00:36.000Z - 25 days ago

Connect Biopharma initiated with an Outperform at Oppenheimer


Connect Biopharma initiated with a Buy at Canaccord

2026-05-26T09:25:05.000Z - 2 months ago

Connect Biopharma initiated with a Buy at Canaccord


Connect Biopharma Holdings Slides: Corporate presentation

May 14, 2026, 7:00 AM EDT - 2 months ago

Connect Biopharma Holdings Slides: Corporate presentation


Connect Biopharma Holdings Earnings release: Q1 2026

May 12, 2026, 9:00 AM EDT - 2 months ago

Connect Biopharma Holdings Earnings release: Q1 2026


Connect Biopharma Holdings Quarterly report: Q1 2026

May 12, 2026, 9:00 AM EDT - 2 months ago

Connect Biopharma Holdings Quarterly report: Q1 2026


Connect Biopharma announces enrollment in Seabreeze STAT study

2026-04-23T13:29:20.000Z - 3 months ago

Connect Biopharma announces enrollment in Seabreeze STAT study


Connect Biopharma director buys $4.0M in common stock

2026-04-01T21:15:48.000Z - 4 months ago

Connect Biopharma director buys $4.0M in common stock


Connect Biopharma Holdings Annual report: Q4 2025

Mar 31, 2026, 4:00 PM EDT - 4 months ago

Connect Biopharma Holdings Annual report: Q4 2025


Connect Biopharma Holdings Earnings release: Q4 2025

Mar 31, 2026, 4:00 PM EDT - 4 months ago

Connect Biopharma Holdings Earnings release: Q4 2025


Connect Biopharma Holdings Transcript: Study result

Mar 30, 2026, 8:00 AM EDT - 4 months ago

Connect Biopharma Holdings Transcript: Study result


Connect Biopharma Holdings Press release: Study result

Mar 30, 2026, 8:00 AM EDT - 4 months ago

Connect Biopharma Holdings Press release: Study result


Connect Biopharma Holdings Slides: Study result

Mar 30, 2026, 8:00 AM EDT - 4 months ago

Connect Biopharma Holdings Slides: Study result


Connect Biopharma announces results from rademikibart study

2026-03-30T11:26:39.000Z - 4 months ago

Connect Biopharma announces results from rademikibart study


Connect Biopharma Holdings Slides: FY 2026

Mar 10, 2026, 8:00 AM EDT - 5 months ago

Connect Biopharma Holdings Slides: FY 2026


Connect Biopharma Holdings Slides: Corporate presentation

Jan 12, 2026, 7:00 AM EST - 7 months ago

Connect Biopharma Holdings Slides: Corporate presentation


Connect Biopharma initiated with a Buy at Lake Street

2025-12-01T13:45:55.000Z - 8 months ago

Connect Biopharma initiated with a Buy at Lake Street


Connect Biopharma Holdings Quarterly report: Q3 2025

Nov 12, 2025, 9:00 AM EST - 9 months ago

Connect Biopharma Holdings Quarterly report: Q3 2025


Connect Biopharma Holdings Earnings release: Q3 2025

Nov 12, 2025, 9:00 AM EST - 9 months ago

Connect Biopharma Holdings Earnings release: Q3 2025


Connect Biopharma Holdings Transcript: Status Update

Nov 3, 2025, 4:15 PM EST - 9 months ago

Connect Biopharma Holdings Transcript: Status Update


Connect Biopharma initiated with a Buy at BTIG

2025-10-31T10:10:32.000Z - 9 months ago

Connect Biopharma initiated with a Buy at BTIG


Connect Biopharma presents data on rademikibart at ERS Congress

2025-09-29T13:21:17.000Z - 11 months ago

Connect Biopharma presents data on rademikibart at ERS Congress


Connect Biopharma Holdings Quarterly report: H1 2025

Aug 13, 2025, 9:00 AM EDT - 1 year ago

Connect Biopharma Holdings Quarterly report: H1 2025


Connect Biopharma Holdings Earnings release: H1 2025

Aug 13, 2025, 9:00 AM EDT - 1 year ago

Connect Biopharma Holdings Earnings release: H1 2025


Connect Biopharma Holdings Slides: Corporate Presentation

Jun 3, 2025, 7:00 AM EDT - 1 year ago

Connect Biopharma Holdings Slides: Corporate Presentation


Connect Biopharma Holdings Quarterly report: Q1 2025

May 15, 2025, 9:00 AM EDT - 1 year ago

Connect Biopharma Holdings Quarterly report: Q1 2025


Connect Biopharma Holdings Earnings release: Q1 2025

May 15, 2025, 9:00 AM EDT - 1 year ago

Connect Biopharma Holdings Earnings release: Q1 2025


Connect Biopharma Holdings Earnings release: H2 2024

Mar 31, 2025, 9:00 AM EDT - 1 year ago

Connect Biopharma Holdings Earnings release: H2 2024


Connect Biopharma Holdings Annual report: H2 2024

Mar 31, 2025, 9:00 AM EDT - 1 year ago

Connect Biopharma Holdings Annual report: H2 2024


Attovia Therapeutics Appoints Chief Financial Officer

Oct 15, 2024, 7:30 AM EDT - 1 year ago

Attovia Therapeutics Appoints Chief Financial Officer


CNTB Stock Dips Amid Biotech Sector Volatility

Oct 9, 2024, 3:55 PM EDT - 1 year ago

CNTB Stock Dips Amid Biotech Sector Volatility


CNTB Stock Surges Over 5% Amid Strong Financial Performance

Oct 2, 2024, 4:14 PM EDT - 1 year ago

CNTB Stock Surges Over 5% Amid Strong Financial Performance


Connect Biopharma Holdings Quarterly report: H1 2024

Sep 5, 2024, 4:00 PM EDT - 2 years ago

Connect Biopharma Holdings Quarterly report: H1 2024


Connect Biopharma Holdings Slides: Corporate Presentation

Aug 6, 2024, 2:00 AM EDT - 2 years ago

Connect Biopharma Holdings Slides: Corporate Presentation


Connect Biopharma Holdings Annual report: H2 2023

Apr 16, 2024, 4:00 PM EDT - 2 years ago

Connect Biopharma Holdings Annual report: H2 2023


Connect Biopharma Holdings Quarterly report: H2 2023

Apr 16, 2024, 4:00 PM EDT - 2 years ago

Connect Biopharma Holdings Quarterly report: H2 2023


Connect Biopharma Holdings Transcript: Study Result

Dec 12, 2023, 8:30 AM EST - 2 years ago

Connect Biopharma Holdings Transcript: Study Result


Connect Biopharma Holdings Press release: Study Result

Dec 12, 2023, 8:30 AM EST - 2 years ago

Connect Biopharma Holdings Press release: Study Result


Connect Biopharma Holdings Slides: Study Result

Dec 12, 2023, 8:30 AM EST - 2 years ago

Connect Biopharma Holdings Slides: Study Result


stevie2times
stevie2times Aug. 3 at 7:03 AM
$CNTB 2 bucks, For Rademikibart that has created a completely new therapeutic Class Hyper -acute Respiratory Biologic. When you bypass the maintenance timeline of Dupixent dominance & capture the immediate point-of care network from the ER w a 300mg IV Push,& stuff a prescription of Rademikibart 600mg for monthly maintenance the addressable financial premium skyrockets. Rademikibart will literally be a Closed Loop Respiratory Franchise that also has Best in Class Eczema data, all this for 2 fkn bucks. Ciao' 😏
2 · Reply
stevie2times
stevie2times Aug. 2 at 4:47 AM
$CNTB 😂 This stock can't catch a bid' Even though July 30th the FDA's DPACC (Division of Pulmonology, Allergy, & Critical Care) green lighted the new protocol arm of the SEABREEZE trial after a 30 day review. The new delivery 300mg IV Push in the same ER setting were no biologic has even attempted is Rademikibart playground. Btw' that DPACC green light last Thurs just completely de'risked the SEABREEZE trial. Ciao' 😏
1 · Reply
SHVR89
SHVR89 Aug. 1 at 10:23 PM
0 · Reply
mikeywo
mikeywo Jul. 31 at 7:39 PM
$CNTB hopefully if we get some good data in Sept , Barry will go on a road show to all the healthcare conferences that occur in the fall and get the word out.
0 · Reply
BennyBoy18
BennyBoy18 Jul. 31 at 4:16 PM
$CNTB As long as James Huang is holding , im holding.
1 · Reply
BennyBoy18
BennyBoy18 Jul. 30 at 12:03 PM
$CNTB always blasts off pre marker and then crashes at marker open lol
1 · Reply
stevie2times
stevie2times Jul. 30 at 7:48 AM
$CNTB Tutes' have been busy scooping the STOPS
1 · Reply
Teshuvah
Teshuvah Jul. 29 at 12:16 PM
0 · Reply
elmono
elmono Jul. 28 at 9:18 PM
$CNTB dipping some more…..charts…what can I say 😂😂😂
1 · Reply
elmono
elmono Jul. 28 at 9:14 PM
$CNTB too funny 😂😂😂
0 · Reply
BennyBoy18
BennyBoy18 Jul. 28 at 3:03 PM
$CNTB tf is happening? Insiders know it failed?
3 · Reply
BennyBoy18
BennyBoy18 Jul. 27 at 8:31 PM
$CNTB fuc i might should have sold at 2.70
0 · Reply
Kings124566
Kings124566 Jul. 24 at 6:23 PM
$CNTB ok, enjoy your shares.
0 · Reply
saprs
saprs Jul. 24 at 3:26 PM
$CNTB Initiated a small $CNTB position.
1 · Reply
Biotech_Beast
Biotech_Beast Jul. 23 at 10:33 AM
$CNTB I'm long this name. The company's drug can go after an indication not covered by $SNY and $REGN 's Dupixent. Two readouts in September, so there could be further run up. https://seekingalpha.com/article/4924516-connect-biopharma-attempting-to-differentiate-rademikibart-from-dupixent
0 · Reply
elmono
elmono Jul. 21 at 3:55 PM
$CNTB how are we doing 😂😂😂
1 · Reply
mikeywo
mikeywo Jul. 21 at 3:23 PM
$CNTB cmon Barry. You have nothing for the market ? Sitting on your hands til Sept is going to put us back to 1.50$
0 · Reply
TheWings977
TheWings977 Jul. 17 at 3:36 PM
$CNTB bought 300 more shares. Not much but we’ll see what happens.
0 · Reply
liloleme4
liloleme4 Jul. 16 at 6:06 PM
$CNTB Good enough price that I added more - not a ton, as I tend to accumulate slowly or as I cash out some profits on other stocks, so still in the 3 digits for shares, but upper three digits now. Will cross into the 4s if another opportunity arises - esp if it goes lower
0 · Reply
Biotech80
Biotech80 Jul. 16 at 2:56 PM
$SOUN @Kjtt Biotech also was on $CNTB from $1.13 sold that one at $2.87 if you want one more was on $ANNX bought that at $4.56 sold at $6.87, I don’t pump stocks for the sake of it l Analyse all and look to sell usually at minimum 50- 100%, Now $SOUN will give me minimum 75% $10 plus and I will not sell anything less with an average of $6.23 now anything lower that this I will add more.
1 · Reply
StockScanners
StockScanners Jul. 16 at 4:31 AM
$CNTB reached 2.45,
0 · Reply
buythedipsisay
buythedipsisay Jul. 15 at 12:05 PM
$CNTB Seabreeze STAT COPD (NCT06940154) has changed from “Recruiting” to “Active, not recruiting.” The registry-derived record shows the study was last updated July 13, 2026, retains a target enrollment of 160 patients, and now lists enrollment as closed.
1 · Reply